AKT1 and esophageal squamous cell carcinoma: Likewise, cell migration assays showed that inhibition of PI3K/AKT signaling by overexpressing PTEN (Figure 3C) or pharmacological blockade (Figure 3D) markedly retarded ESCC cell migration.